>
pdufa.bio

Topical Roflumilast

Updated ยทnext FDA decision on the calendar

Topical Roflumilast is a Arcutis Biotherapeutics Inc. program. Every date links its source.

ARQT catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Arcutis Biotherapeutics Inc. (ARQT). We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Sep 2026ARQT

Questions

When is Topical Roflumilast's next FDA decision or readout?

No upcoming catalyst is on our calendar for Topical Roflumilast; no FDA decisions are on record below.

What happened at Topical Roflumilast's most recent FDA decision?

No FDA decision for Topical Roflumilast is in our archive yet.

Who makes Topical Roflumilast?

Arcutis Biotherapeutics Inc. (ARQT).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.